Key result
MR cytometry detects higher Small Dense Cell Fraction in MASH patients versus healthy subjects.
Why the study?
The diagnostic gold standard for MASH requires invasive biopsy, and non-invasive methods for evaluating hepatic inflammation remain lacking.
Does MR cytometry accurately quantify pathological changes in liver cell size and density to non-invasively assess inflammation in MASH?
Cross-Sectional (n=10)
No
Does MR cytometry accurately quantify pathological changes in liver cell size and density to non-invasively assess inflammation in MASH?
MR cytometry is a feasible non-invasive imaging technique that can quantify liver cell size and density to identify inflammation in MASH, potentially reducing the need for invasive biopsies.
May aid non-invasive MASH inflammation assessment; leaves open prospective validation before clinical use.
The current diagnostic gold standard for metabolic dysfunction-associated steatohepatitis (MASH) requires invasive biopsy to assess steatosis, inflammation, and ballooning. While MRI-based proton density fat fraction (PDFF) and MR elastography address steatosis and fibrosis, non-invasive methods for evaluating hepatic inflammation remain lacking. This study developed a diffusion MRI (dMRI)-based MR cytometry technique to map liver cellular properties, including MRI-derived cell size (excluding fat content) and cell density. Validation through histology-driven simulations and ex vivo MRI of fixed human liver specimens demonstrated that stromal regions exhibit smaller MRI-derived cell sizes and higher cell densities than both normal and fatty tissues. An in vivo feasibility study, conducted on healthy subjects (n = 5) and MASH patients (n = 5) using a clinical 3 T MRI system, further showcased the potential of MR cytometry to characterize pathological changes in liver microstructure.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2025) conducted a cross-sectional in Metabolic dysfunction-associated steatohepatitis (MASH) (n=10). MR cytometry vs. Healthy subjects was evaluated on Small Dense Cell Fraction (SDCF). MR cytometry demonstrated that the Small Dense Cell Fraction, reflecting cell size and density, was significantly higher in patients with MASH compared to healthy subjects.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: